Volume 6, Number 2—April 2000
Dispatch
Erythromycin Resistance in Streptococcus pyogenes in Italy
Table 2
Patients treated (no.) | Treatment failed (%) | p value | |
---|---|---|---|
Erythromycin-susceptible | 25 | 3 (12) | |
Erythromycin-resistant | 19 | 7 (36.8) | 0.07a |
- CRb | 6 | 6 (100) | 0.0001a |
- other phenotypes | 13 | 1 (7.6) | 1.0a; 0.0002c |
Total | 44 | 10 (22.7) |
aFor comparison of percentage of failure with erythromycin-susceptible.
bCR = Constitutive-type resistance.
cFor comparison of percentage of failure between CR and other phenotypes of resistance.
References
- Bisno AL. Group A streptococcal infections and acute rheumatic fever. N Engl J Med. 1991;325:783–93.PubMedGoogle Scholar
- Kaplan EL. The resurgence of group A streptococcal infections and their sequelae. Eur J Clin Microbiol Infect Dis. 1991;10:55–7. DOIPubMedGoogle Scholar
- Moses AE, Ziv A, Harari M, Rahav G, Shapiro M, Englehard D. Increased incidence and severity of Streptococcus pyogenes bacteremia in young children. Pediatr Infect Dis J. 1995;14:767–70. DOIPubMedGoogle Scholar
- Peter G. Streptococcal pharyngitis: current therapy and criteria for evaluation of new agents. Clin Infect Dis. 1992;14(Suppl 2):S218–23.PubMedGoogle Scholar
- Schito GC, Pesce A, Marchese AJ. The role of macrolides in Streptococcus pyogenes pharyngitis. J Antimicrob Chemother. 1997;39:562–5. DOIPubMedGoogle Scholar
- Lowbury EJL, Hurst L. The sensitivity of staphylococci and other wound bacteria to erythromycin, oleandomycin and spiramycin. J Clin Pathol. 1959;12:163–4. DOIPubMedGoogle Scholar
- Maruyama S, Yoshiota H, Fujita K, Takimoto M, Satake Y. Sensitivity of group A streptococci to antibiotics. Am J Dis Child. 1979;133:151–4.PubMedGoogle Scholar
- Seppala H, Nissinen A, Jarvinen H, Huovinen S, Henriksson T, Herva E, Resistance to erythromycin in group A streptococci. N Engl J Med. 1992;326:292–7.PubMedGoogle Scholar
- Hsueh PR, Chen HM, Huang AH, Wu JJ. Decreased activity of erythromycin against Streptococcus pyogenes in Taiwan. Antimicrob Agents Chemother. 1995;39:2239–42.PubMedGoogle Scholar
- Stingemore N, Francis GRJ, Toohey M, McGechie DB. The emergence of erythromycin resistance in Streptococcus pyogenes in Fremantle, Western Australia. Med J Aust. 1989;150:626–31.PubMedGoogle Scholar
- Gentry JL, Burns WW. Antibiotic resistant streptococci. Am J Dis Child. 1980;133:801.
- Garcia-Bermejo I, Cacho J, Orden B, Alos J, Gomez-Garces JL. Emergence of erythromycin-resistant, clindamycin-susceptible Streptococcus pyogenes isolates in Madrid, Spain. Antimicrob Agents Chemother. 1998;42:989–90.PubMedGoogle Scholar
- Orden B, Perez-Trallero E, Montes M, Martinez R. Erythromycin resistance of Streptococcus pyogenes in Madrid. Pediatr Infect Dis J. 1998;17:470–3. DOIPubMedGoogle Scholar
- Cornaglia G, Ligozzi M, Mazzariol A, Valentini M, Orefici G, Fontana R. Rapid increase of resistance to erythromycin and clindamycin in Streptococcus pyogenes in Italy, 1993-1995. Emerg Infect Dis. 1996;2:339–42. DOIPubMedGoogle Scholar
- Cocuzza C, Blandino G, Mattina R, Nicoletti F, Nicoletti G. Antibiotic susceptibility of group A streptococci in 2 Italian cities: Milano and Catania. Microb Drug Resist. 1997;3:379–84. DOIPubMedGoogle Scholar
- Cornaglia G, Ligozzi M, Mazzariol A. Resistance of Streptococcus pyogenes to erythromycin and related antibiotics in Italy. Clin Infect Dis. 1998;27(Suppl 1):S87–92. DOIPubMedGoogle Scholar
- Bassetti M, Mantero E, Gatti G, Di Biagio A, Bassetti D. Streptococcus pyogenes erythromycin resistance in Italy. Emerg Infect Dis. 1999;5:302–3. DOIPubMedGoogle Scholar
- Seppala H, Nissinen A, Yu Q, Houvinen P. Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. J Antimicrob Chemother. 1993;32:885–91. DOIPubMedGoogle Scholar
- Sutcliffe J, Tait-Kamradt A, Wondrack L. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob Agents Chemother. 1996;40:1817–24.PubMedGoogle Scholar
- National Committee for Clinical Laboratory Standard Performance Standards for antimicrobial disk susceptibility tests. Document M2- A6. Villanova (PA): The Committee; 1997.
- National Committee for Clinical Laboratory Method for dilution for antimicrobial susceptibility tests for bacteria that grow aerobically. Document M7- A4. Villanova (PA): The Committee; 1997.
- Sanders E, Foster MT, Scott D. Group A beta-hemolytic streptococci resistant to erythromycin and lincomycin. N Engl J Med. 1968;278:538–40.PubMedGoogle Scholar
- Phillips G, Parratt D, Orange GV, Harper I, McEwan H, Young N. Erythromycin resistant Streptococcus pyogenes. J Antimicrob Chemother. 1990;25:723–4. DOIPubMedGoogle Scholar
- Lode H, Boeckh M, Scaberg T. Human pharmacokinetics of macrolide antibiotics. In: Macrolides. Chemistry, pharmacology and clinical uses. Bryskier A, Butzler JP, Neu HC, Tulkens PM, editors. Paris: Arnette Blackwell; 1993; p. 409-20.
Page created: December 16, 2010
Page updated: December 16, 2010
Page reviewed: December 16, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.